Viking Therapeutics (NASDAQ:VKTX) is gearing up to announce its quarterly earnings on Wednesday, 2026-02-11. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Viking Therapeutics will report an earnings per share (EPS) of $-0.90.
Anticipation surrounds Viking Therapeutics’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings Track Record
During the last quarter, the company reported an …